Skip to main content
. 2016 Feb 18;42(1):99–107. doi: 10.1007/s13318-016-0324-7
No statistically significant differences in blood aggregation and pharmacokinetics of clopidogrel and its metabolites were found between CYP3A4*1G carriers and non-carriers.